Entero Therapeutics Statistics
Total Valuation
ENTO has a market cap or net worth of $2.92 million. The enterprise value is $3.70 million.
Important Dates
The next confirmed earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ENTO has 4.77 million shares outstanding. The number of shares has increased by 459.34% in one year.
| Current Share Class | 4.77M |
| Shares Outstanding | 4.77M |
| Shares Change (YoY) | +459.34% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.71% |
| Owned by Institutions (%) | 2.86% |
| Float | 4.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.90 |
| Quick Ratio | 0.00 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -410.21 |
Financial Efficiency
Return on equity (ROE) is -33.24% and return on invested capital (ROIC) is -6.46%.
| Return on Equity (ROE) | -33.24% |
| Return on Assets (ROA) | -5.21% |
| Return on Invested Capital (ROIC) | -6.46% |
| Return on Capital Employed (ROCE) | -13.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$12.57M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ENTO has paid $14.86 million in taxes.
| Income Tax | 14.86M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +111.56% in the last 52 weeks. The beta is 0.81, so ENTO's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +111.56% |
| 50-Day Moving Average | 0.48 |
| 200-Day Moving Average | 0.50 |
| Relative Strength Index (RSI) | 64.05 |
| Average Volume (20 Days) | 15,552,422 |
Short Selling Information
The latest short interest is 283,776, so 5.95% of the outstanding shares have been sold short.
| Short Interest | 283,776 |
| Short Previous Month | 648,698 |
| Short % of Shares Out | 5.95% |
| Short % of Float | 6.38% |
| Short Ratio (days to cover) | 0.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.34M |
| Pretax Income | n/a |
| Net Income | -25.14M |
| EBITDA | -7.34M |
| EBIT | -7.34M |
| Earnings Per Share (EPS) | -$6.03 |
Full Income StatementBalance Sheet
The company has $59,352 in cash and $835,609 in debt, giving a net cash position of -$776,257 or -$0.16 per share.
| Cash & Cash Equivalents | 59,352 |
| Total Debt | 835,609 |
| Net Cash | -776,257 |
| Net Cash Per Share | -$0.16 |
| Equity (Book Value) | 56.46M |
| Book Value Per Share | -1.09 |
| Working Capital | 54.72M |
Full Balance SheetCash Flow
| Operating Cash Flow | -6.29M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.29M |
| FCF Per Share | -$1.32 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |